Your browser doesn't support javascript.
loading
Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful
Korean Journal of Radiology ; : 54-70, 2017.
Article in English | WPRIM | ID: wpr-208835
ABSTRACT
Diffuse large B cell lymphoma (DLBCL) is the most common histological subtype of Non-Hodgkin's lymphoma. As treatments continues to evolve, so do imaging strategies, and positron emission tomography (PET) has emerged as the most important imaging tool to guide oncologists in the diagnosis, staging, response assessment, relapse/recurrence detection,and therapeutic decision making of DLBCL. Other imaging modalities including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and conventional radiography are also used in the evaluation of lymphoma. MRI is useful for nervous system and musculoskeletal system involvement and is emerging as a radiation free alternative to PET/CT. This article provides a comprehensive review of both the functional and morphological imaging modalities, available in the management of DLBCL.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Lymphoma, Non-Hodgkin / Magnetic Resonance Imaging / B-Lymphocytes / Radiography / Lymphoma, B-Cell / Ultrasonography / Decision Making / Positron-Emission Tomography / Diagnosis / Positron Emission Tomography Computed Tomography Type of study: Diagnostic study Language: English Journal: Korean Journal of Radiology Year: 2017 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Lymphoma, Non-Hodgkin / Magnetic Resonance Imaging / B-Lymphocytes / Radiography / Lymphoma, B-Cell / Ultrasonography / Decision Making / Positron-Emission Tomography / Diagnosis / Positron Emission Tomography Computed Tomography Type of study: Diagnostic study Language: English Journal: Korean Journal of Radiology Year: 2017 Type: Article